KYORIN Pharmaceutical Co.,Ltd.'s total assets for Q4 2024 were ¥193.62B, an increase of 1.64% from the previous quarter. JP:4569 total liabilities were ¥57.33B for the fiscal quarter, a -5.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.